The Notch ligand Jagged1 as a target for anti-tumour therapy
The Notch pathway is increasingly attracting attention as a source of therapeutic targets for cancer. Ligand-induced Notch signalling has been implicated in various aspects of cancer biology; as a consequence pan-Notch inhibitors and therapeutic antibodies targeting one or more of the Notch receptor...
Main Authors: | Demin eLi, Massimo eMasiero, Alison H Banham, Adrian L Harris |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00254/full |
Similar Items
-
The oncogenic role of Jagged1/Notch signaling in cancer
by: Meng-xi Xiu, et al.
Published: (2020-09-01) -
The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence
by: Jianping Zhang, et al.
Published: (2021-03-01) -
Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy
by: Nicole M. Marchetto, et al.
Published: (2020-09-01) -
Notch Signaling Function in the Angiocrine Regulation of Tumor Development
by: Alexandre Trindade, et al.
Published: (2020-11-01) -
Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
by: Maria Teresa Palano, et al.
Published: (2020-09-01)